Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
22.80
-0.34 (-1.47%)
Jun 16, 2026, 12:26 PM EDT - Market open
Surrozen Market Cap
Surrozen has a market cap or net worth of $264.72 million as of June 16, 2026. Its market cap has increased by 280.26% in one year.
Market Cap
264.72M
Enterprise Value
163.31M
1-Year Change
280.26%
Ranking
Category
Stock Price
$22.80
Market Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $264.72M, an increase of 119.40%. That is a compound annual growth rate of 15.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 264.72M | 25.64% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 284.66M |
| Inhibikase Therapeutics | 284.61M |
| Nuvectis Pharma | 284.09M |
| Bicycle Therapeutics | 282.74M |
| Cartesian Therapeutics | 279.42M |
| Armata Pharmaceuticals | 278.15M |
| Eledon Pharmaceuticals | 275.97M |
| Niagen Bioscience | 275.35M |